Adynovate recombinant and Oxymorphone Extended-Release Tablets
Determining the interaction of Adynovate recombinant and Oxymorphone Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Adynovate (recombinant)
Generic Name: oxymorphone
Brand name: Opana, Opana ER, Numorphan HCl
Synonyms: Oxymorphone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adynovate recombinant-Oxymorphone Hydrochloride
- Adynovate recombinant-Oxymorphone Injection
- Adynovate recombinant-Oxymorphone Tablets
- Adynovate recombinant-Oxytocin
- Adynovate recombinant-Oxytocin Intravenous, Intramuscular
- Adynovate recombinant-Oxytrol
- Oxymorphone Extended-Release Tablets-Adzenys ER
- Oxymorphone Extended-Release Tablets-Adzenys ER Oral Suspension
- Oxymorphone Extended-Release Tablets-Adzenys XR-ODT
- Oxymorphone Extended-Release Tablets-Aemcolo
- Oxymorphone Extended-Release Tablets-Aerobid
- Oxymorphone Extended-Release Tablets-Aerobid-M